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Intr
Mortality among leukemia patients admitted to the
intensive care unit remains high [1] and bleeding com-
plications are common in particular among thrombocy-
topenic patients [2]. Platelet levels measured in
thrombocytopenic ICU patients reflect both the inherit
and transfused platelets. ICU patients generally receive a
high amount of transfusions [3] and hematological ICU
patients are no exception.
Objectives
Our aim was to describe the number and type of trans-
fusions given to patients with haematological malignan-
cies admitted to an intensive care unit. Furthermore, we
wanted to test if there was an association between the
number of platelet transfusions given in the first three
days after arrival at the ICU and 30 day-mortality.
Methods
This was a retrospective observational study with data
from patients with ALL, AML and MDS admitted to the
ICU at Rigshospitalet, Copenhagen University Hospital
2008-2012. Data were extracted from the electronic ICU
patient charts, blood bank database and national regis-
tries. To test for an association between platelet transfu-
sions and 30-day mortality, we used logistic regression
adjusted by SAPS II.
Results
Our cohort included 112 patients. 104 (93 %) received at
least one blood product with a median of 20 blood pro-
ducts (IQR 7.5-52.5). Eighty-five (76%) patients received
one or more platelet transfusions (median 12, IQR 6-
37). During the first three days in the ICU, 58 patients
received at least one platelet transfusion (concentrate
from 4 donors) (median 5, IQR 3-8). No association
between the number of platelet transfusions given dur-
ing the first three days in the ICU and 30-day mortality
was observed (HR 1.004, 95%CI 0.895-1.126).
Conclusions
In this cohort of patients with haematological malignan-
cies admitted to the intensive care unit the use of blood
products was high. Platelet transfusion given in the first
three days in the ICU was not associated with increased
30-day mortality.
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